Table of Contents
2008 - 23 (3)
- FDA notifications. Changes to ART guidelines detailed by the FDA.
- FDA notifications. Pediatric formulation of lamivudine approved.
- FDA notifications. Revised atazanavir package insert.
- FDA notifications. FDA grants accelerated approval for etravirine.
- FDA notifications. Generic lamivudine tentatively approved.
- FDA notifications. FDA tentatively approves generic atazanavir.
- Status report on the female condom: what will increase use in the U.S.?
- Late diagnosis/entry into HIV care can result in early deaths among infected. Study highlights human year toll.
- Positive results involving HIV prevention for the mentally ill population. Motivational interviewing is used.
- Full viral suppression newest trend seen in the "post-HAART" era. New immunotherapy treatment could help with trend.